Descripción del título
Advances in cancer research...
ADVANCES IN CANCER RESEARCH, VOLUME 40
Monografía
monografia Rebiun25976474 https://catalogo.rebiun.org/rebiun/record/Rebiun25976474 m o d | cr -n--------- 750720s1983 nyua ob 001 0 eng d 52013360 1-281-45113-4 9786611451134 0-08-056222-1 UPVA 997187099903706 CBUC 991013419665106708 CBUC 991010400663306709 CBUC 991010400663306709 CBUC 991010400663306709 MiAaPQ MiAaPQ MiAaPQ eng 616.99/4 616.994 Advances in cancer research. Volume 40 electronic resource] edited by George Klein New York Academic Press 1983 New York New York Academic Press 1 online resource (453 p.) 1 online resource (453 p.) Text txt computer c online resource cr Advances in cancer research v. 40 Description based upon print version of record Includes bibliographical references and index Front Cover; Advances in Cancer Research, Volume 40; Copyright Page; Contents; Contributors to volume 40; Chapter 1. 5-Methylcytosine, Gene Regulation, and Cancer; I. Introduction; II. Basic Concepts; III. Evidence for Gene Regulation by DNA Modification; IV. Cause or Effect: Necessary but Not Sufficient; V. Induction of Gene Expression by 5-Azacytidine; VI. Cancer-A Disease Resulting from Abnormal Differentiation; VII. 5-Methylcytosine Levels in Tumorigenic Cells; VIII. Carcinogens and Enzymatic DNA Methylation; IX. Oncogenes; X. Conclusions; References Chapter 2. lmmunobiology of Infection with Human CytomegalovirusI. Introduction; II. Herpesviruses; III. Cytomegaloviruses, HCMV; IV. HCMV-Host Cell Interactions; V. Epidemiology of the Infection with HCMV; VI. Diagnosis of HCMV Infection; VII. Clinical Significance of HCMV Infections; VIII. Oncogenic Potential of HCMV; IX. Immunopathology; X. Latency/Reactivation; XI. Replication of HCMV in Leukocytes; XII. Effects of HCMV on Leukocytes; XIII. Immunity against Infections with HCMV, General Aspects; XIV. Humoral Immune Responses; XV. Cell-Mediated Immunity XVI. Nonspecific Defense Mechanisms against HCMV InfectionXVII. Vaccine and Therapy Problems; XVIII. Conclusions; References; Chapter 3. Genetics of Resistance to Virus-Induced Leukemias; I. Introduction; II. The Initial Link between Viruses and Leukemias; III. Characteristics of the Retrovirus Family; IV. Expression in Inbred Mouse Strains of Antigens Associated with MuLV; V. Genetics of Susceptibility to Viral Infection; VI. Prospects for Control of Human Leukemia; References; Chapter 4. Breast Carcinoma Etiological Factors; I. Introduction; II. Heritage; III. Menses, Marital State, Parity IV. Breast-FeedingV. Contraceptives; VI. Benign Epithelial Diseases of the Breast; VII. Hormonal Factors; VIII. Cancer; IX. Iatrogenic Factors; X. Immunological Factors; XI. Viral Aspects of Human Breast Cancer; XII. Dietary Factors; XIII. Psychosomatic Factors; XIV. Discussion and Concluding Remarks; References; Chapter 5. Treatment of Acute Leukemia-Advances in Chemotherapy, Immunotherapy, and Bone Marrow Transplantation; I. Introduction; II. The Strategy for Treating Acute Leukemia; III. Classification and Prognostic Factors; IV. Chemotherapy of Acute Leukemia; V. Immunotherapy VI. Bone Marrow TransplantationVII. Supportive Treatment; VIII. Prospects for the Future; References; Chapter 6. The Forty-Year-Old Mutation Theory of Luria and Delbrück and Its Pertinence to Cancer Chemotherapy; I. Introduction; II. The Somatic Mutation Theory (1943); III. The Fluctuation Test of Law Pointing to the Origin of Methotrexate-Resistant Leukemia Cells; IV. Wide Fiuctuations in the Degree and Duration of Response of Neoplasms to Chemotherapy in Similarly Staged and Treated Individuals V. Effective but Noncurative Chemotherapy Consistently Increases the Survival Time Variance of Treatment Failures ADVANCES IN CANCER RESEARCH, VOLUME 40 English Cáncer- Research Oncology, Experimental Electronic books Klein, George Advances in cancer research (CKB)954926956844 (DLC)2011236561 (OCoLC)60625515 2162-5557 0-12-006640-8